|
|
|
|
|
|
||||||||
|
||||||||
![]() Click here for low bandwidth version |
USD
USD
|
EUR
EUR
|
GBP
GBP
|
Converter
Converter
|
||
|
|
|||||
Gold (INR/Gram)
Gold (INR/Gram)
|
Silver (INR/Kilo)
Silver (INR/Kilo)
|
||||
| LIVE DATA TERMINALS: Nifty50 | IT | Bank | |
|
|
Pfizer | Pfizer Limited | Live NSE Share Price Quotes Pfizer | Realtime Pfizer Chart |
| LIVE QUOTES - LIST OF ALL NSE STOCKS WITH CURRENT PRICES |
|
more information on Pfizer Limited from bse
|
|||||||||||||||||||||||||
Pfizer Limited - 3 Months Candlestick Chart |
|
Healthcare Business Recap: Pfizer REJECTION, Alexion in the Big Leagues
Healthcare Business Recap: Pfizer REJECTION, Alexion in the Big Leagues
Wall St. Cheat Sheet - 1 hour ago By Mark Lawson Shares of Bayer (BAYRY.PK) slip, but Onyx Pharmaceuticals (NASDAQ:ONXX) moves up following word that a Phase 3 trial of Nexavar tablets in patients with certain lung cancers failed to meet its primary endpoint of improving overall ...
Bayer's Nexavar falters in another lung cancer trial - FiercePharmaBayer's Nexavar fails in another lung cancer study - PMLiVE
Prodigy Generics and eVenus Announce the Launch of Oncology Injectable Irinotecan.
Prodigy Generics and eVenus Announce the Launch of Oncology Injectable Irinotecan.
MarketWatch (press release) - 4 hours ago AUSTIN, Texas, May 22, 2012 /PRNewswire via COMTEX/ -- Prodigy Generics, a division of Prodigy Health Supplier Corporation (PHS), has launched injectable irinotecan.
Fired Pfizer rep sues, claiming pregnancy-related discrimination
Fired Pfizer rep sues, claiming pregnancy-related discrimination
FiercePharma - 7 hours ago A Pfizer ($PFE) sales rep has sued the company, saying she was fired because of her pregnancy, Pharmalot reports. Marie Hand, who repped for King Pharmaceuticals when Pfizer bought the company, says she notified the company she was pregnant just weeks ...
Analysis And Valuation: Johnson & Johnson, Pfizer, And Merck
Analysis And Valuation: Johnson & Johnson, Pfizer, And Merck
Seeking Alpha - 7 hours ago In this article, we take a look at Johnson & Johnson (JNJ), Pfizer (PFE), and Merck (MRK). All three enterprises are rated "Buy.
FDA Reviewer Recommends Against Approval Of Pfizer Drug
FDA Reviewer Recommends Against Approval Of Pfizer Drug
Wall Street Journal - 7 hours ago By Jennifer Corbett Dooren Of DOW JONES NEWSWIRES WASHINGTON (Dow Jones)--A Food and Drug Administration medical reviewer recommended the agency not approve a drug developed by a Pfizer Inc. (PFE) subsidiary to treat a rare genetic disorder that ...
FDA staff shoot down Pfizer rare disease drug - Reuters
|
|
About Indiansplash.com |
Disclaimer |
Privacy Policy |
Terms of Use |
Advertise |
Sitemap |
Contact Us
|